Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 02/11/2025 12:35:43 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 3196
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
49171
Seemingly contrary. Over differences are over
(1)
RusticBum
09/23/2018 8:19:10 PM
49170
Nothing strange at all about not paying someone
(2)
Drano
09/23/2018 7:52:35 PM
49169
No, the board is not "alarmingly paranoid."
(5)
Drano
09/23/2018 7:50:29 PM
49168
The timing just seems weird to me. IPIX is close
smokenhot
09/23/2018 7:37:17 PM
49167
What makes you think that lesions show up fully
(2)
RusticBum
09/23/2018 5:27:56 PM
49166
My bet is you get to stock the Scotch, maybe
incubus
09/23/2018 5:14:05 PM
49165
Please don't let facts get in the way of your
(4)
Drano
09/23/2018 4:37:48 PM
49164
As you said Brilacidin does not have systemic
(2)
RusticBum
09/23/2018 4:17:29 PM
49163
Well here we are folks at the last trading week
(12)
Kelt
09/23/2018 1:42:25 PM
49162
Ahhh Yes. A little word twisting here,a little
(2)
Kelt
09/23/2018 1:40:12 PM
49161
Menon is in his mid-70's and was already on half
Drano
09/23/2018 1:36:55 PM
49160
Is it possible that Menon's termination has
smokenhot
09/23/2018 1:18:21 PM
49159
We have only people's word for it that they are
(2)
Drano
09/23/2018 12:58:15 PM
49158
That is incorrect. Bril-OM PREVENTS lesions from
(6)
Drano
09/23/2018 12:40:39 PM
49157
If both Galera's GC4419 and Brilacidin get
(1)
RusticBum
09/23/2018 11:57:00 AM
49156
Accusing long term investors of being short multi
(2)
bejamin
09/23/2018 11:42:25 AM
49155
It's always good to have more than one treatment
(3)
Drano
09/22/2018 3:41:30 PM
49154
Could be a second line treatment after B-OM was
Trading Pro Broker
09/22/2018 3:36:35 PM
49153
NO way will an insurance company pay for that
(2)
smokenhot
09/22/2018 3:24:06 PM
49152
He's accusing long-time posters of being
(5)
Drano
09/22/2018 2:27:16 PM
49150
Take a look at Galas OM drug. Its
(1)
Trading Pro Broker
09/22/2018 1:38:41 PM
49149
Id like to see Leo take half his compensation
(2)
Commando911
09/22/2018 1:19:15 PM
49148
I have never heard of a long multi-identity in
(2)
petemantx
09/22/2018 1:10:28 PM
49147
Your right. That would be
Trading Pro Broker
09/22/2018 11:11:42 AM
49146
A reminder on how to use the Ignore feature:
Drano
09/22/2018 11:02:08 AM
49145
It's typical of many companies to have a large
(4)
Drano
09/22/2018 11:00:23 AM
49144
Multi identities on both sides create so much
(2)
bejamin
09/22/2018 10:59:06 AM
49143
I dont think it is a surprise. If it surprises
Trading Pro Broker
09/22/2018 10:48:51 AM
49142
Glad you're not running the company!
(1)
bejamin
09/22/2018 10:43:09 AM
49141
really, it is better not to respond to trolling
(1)
Drano
09/22/2018 10:00:01 AM
49140
So you think IPIX will begin testing on autism,
(1)
smokenhot
09/22/2018 9:01:20 AM
49139
Well seeing as you came from Yahoo I can
bejamin
09/22/2018 5:10:05 AM
49138
I don't know why this comes as any surprise. Dr.
(12)
Drano
09/21/2018 9:59:42 PM
49137
Yup 1 month here and 5 years on Yahoo. Maybe you
(4)
smokenhot
09/21/2018 9:19:33 PM
49136
No they have not. IPIX has other pre clinical
bejamin
09/21/2018 8:48:07 PM
49135
They have ALL gone thru Pre Clinical. What don't
smokenhot
09/21/2018 8:25:49 PM
49134
To bring new drugs online. IPIX has other drugs
bejamin
09/21/2018 7:37:42 PM
49133
Why would they restart R&D? They are a clinical
(2)
smokenhot
09/21/2018 6:31:27 PM
49132
Arent 18M of those options? Cant exercise
Trading Pro Broker
09/21/2018 6:25:43 PM
49131
As of 6/19/18 Menon has over 33M reasons to see
(1)
Mo
09/21/2018 6:06:58 PM
49130
Totally agree. He'll probably get board payments
incubus
09/21/2018 6:04:21 PM
49129
14% marked today! Go IPIX!!!
(1)
AlanC
09/21/2018 5:53:25 PM
49128
I wondered why he needed to hang around. His work
Trading Pro Broker
09/21/2018 5:52:29 PM
49127
I think scgmck1's post got spell checked from
(2)
Mo
09/21/2018 5:39:37 PM
49126
Who's employment?
Loose Lips
09/21/2018 5:29:36 PM
49125
8K out on the company website. Says mean on his
scgmck1
09/21/2018 5:04:11 PM
49124
They are running out of time. Cover those shorts
incubus
09/21/2018 4:08:53 PM
49123
Close at .299 again? hahaha they just can't allow
Drano
09/21/2018 4:03:10 PM
49122
I agree but I am not expecting news until 9/30
(3)
AlanC
09/21/2018 3:54:18 PM
49121
No prisoners!
(1)
incubus
09/21/2018 3:42:55 PM
Newer
Older
Recent Articles
York University's IEP Bridging Program: Empowering New Graduates
Cornerstone Funds Release Annual Financial Reports for Stakeholders
Daxor Corporation Achieves Strong Financial Results and Growth
Taiwan Semiconductor's Bold $100 Billion U.S. Expansion Plans
AllenComm Named Top Content Provider for Cultural Growth 2025
Codoxo Reveals Innovative AI Agent for Data Integrity in Healthcare
FDA's Latest Approvals Enhance Patient Care and Safety
PennantPark Investment Corp Declares Monthly Share Distribution
Enstar Group Completes Major Transaction with Atrium Syndicate
Silvaco Strengthens Its EDA Portfolio with Cadence Acquisition
Secure Your Place: Regeneron Pharmaceuticals Investors Alert
Sprott Focus Trust, Inc. Announces Quarterly Share Distribution
Safe Harbor Financial Enhances Financial Flexibility Through Debt Adjustment
Federal Reserve's Williams Discusses Tariffs and Inflation Impact
NVIDIA Stock Surges Amid Tariff Concerns: What Investors Know
AAR Corp Strikes Exclusive Deal for PW4000 Engine Components
Celebrating Gord Hicks: A Commitment to Youth Wellness
NeuroPace Achieves Significant Growth with Latest Financials
Insights on Nevro's Q4 and Full-Year 2024 Financial Reports
Fuel Tech's Financial Performance: Gains and Challenges Ahead
Robex Resources Secures $130 Million for Kiniero Gold Project
Transformative Growth: The Ten-Year Journey of HealthEquity
FTAI Aviation Ltd Investors Urged to Take Action Soon
Con Edison Unveils Major Common Stock Offering Announcement
Uniti Group Inc. Invites Investors to Upcoming Conference
Wyndham Hotels & Resorts Announces Increased Cash Dividend
Understanding Recent Trends Impacting Wells Fargo Stock Value
Aspen Aerogels Set to Showcase Innovations at Industry's Top Event
CMB.TECH Acquires Stake in Golden Ocean for Growth Strategy
IGT Triumphs with Seven Awards, Setting Industry Standards
Box, Inc. Reflects on Q4 Success While Adjusting Expectations
Precision Optics Strengthens Board with Buell Duncan Appointment
Breezy Med Transforms Healthcare with Innovative Solutions
Canacol Energy: Upcoming Financial Results and Conference Call Details
Pixalate Reveals February 2025 UK Publisher Rankings Insights
Dentsply Sirona Set to Engage in Global Healthcare Conference
Understanding the Long-Term Value of Amphenol Stock Ownership
Top Mobile Apps and Websites Revealed in Spain Rankings
Supernus Pharmaceuticals Announces Key Investor Conference Dates
Pixalate Reveals Mobile App Publisher Rankings for February 2025
Repay Holdings Faces Challenges Amid Customer Shifts and Reviews
Pixalate's Insights on Ad Quality in Mobile & Web Publishers
ChargePoint Releases Impressive Q4 Results and Future Outlook
Pixalate Unveils February 2025 Canada Publisher Rankings
Newmark Unveils Comprehensive 2025 North American Market Insights
Insights from Pixalate's Top Publisher Rankings for February
Unlocking Brazil's Ad Traffic Quality with February Rankings
Mike Clear Recognized as a Leader in Housing Finance for 2025
FCP Strengthens Market Position with New Property Acquisition
Leadership Changes Enhance Growth Strategy at Precision Optics